On February 25, 2016, Ernest Mario, Ph.D., advised Kindred Biosciences, Inc. of his intention to retire as a director of the company on the date of the company's 2016 Annual Stockholders' Meeting, which is scheduled to occur on May 23, 2016. Dr. Mario has served as a member of the company's Board of Directors since February 15, 2013 and currently serves as the Chairman of the company's Audit Committee and as a member of its Compensation Committee and Nominating and Corporate Governance Committee. Dr. Mario has provided distinguished service to the company, and his decision to retire as a director is not the result of any disagreement with other Board members or with the company's management.
Kindred Biosciences, Inc.
Equities
KIN
US4945771099
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |